GW Pharmaceuticals announces that EPIDYOLEX® (cannabidiol) has been reclassified by the UK Home Office as a Schedule 5 drug Nasdaq: $gwph ⁦⁦@GreenwichBio⁩ $tbp ⁦@TetraBioPharma⁩ $apha $MRK $PFE  https://t.co/nn3BYDP9MU